Table 2.
Drugs targeting HIF/HIF mediated metabolic enzymes
| Drug | Target | Tumor | Ref |
|---|---|---|---|
| Atorvastatin | HIF-1α | Burkitt’s Lymphoma | [115] |
| Oxaliplatin | HIF-1α | Colorectal cancer | [116] |
| Tamoxifen | HIF-1α | Breast cancer | [109] |
| Trichostatin A | HIF-1α | Cervical cancer | [117] |
| Diacetoxyscirpenol | HIF-1α | Liver cancer | [118] |
| Metformin | HIF-1α | Breast cancer | [119] |
| Metformin | HIF-1α/GLUT, HK2, PKM, LDH | Cervical cancer | [120] |
| Ginsenoside Compound K | HIF-1α/PDK1 | Lung cancer | [121] |
| Dovitinib | HIF-1α/GLUT | Lung cancer | [112] |
| Metformin | HIF-1α/PDH | Oral cancer | [110] |
| Cetuximab | HIF-1α/LDHA | Head and neck cancer | [111] |
| Troxacitabine | HIF-1α/PGK | Lung cancer | [122] |